News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Romanos Sklavenitis-Pistofidis: Establishing targeted therapy for Multiple Myeloma with 1q+
Romanos Sklavenitis-Pistofidis/LinkedIn
Mar 15, 2025, 17:51

Romanos Sklavenitis-Pistofidis: Establishing targeted therapy for Multiple Myeloma with 1q+

Romanos Sklavenitis-Pistofidis, Instructor at Dana-Farber Cancer Institute, shared a post on X about a paper he coauthored with colleagues published in Blood Journal:

“Our paper on establishing targeted therapy for MM with 1q+ is online ahead of print in Blood Journal with Liz Lightbody, Mairead Reidy, Irene Ghobrial, Gaddy Getz and Salomon Manier! 

We used a variety of approaches, including dependency screens, drug screens, scRNA-seq of patient tumors with subclonal 1q+, and single-cell cloning of a MM cell line! Tweetorial to follow upon publication!”

“Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1q+”

Authors: Romanos Sklavenitis-Pistofidis, Elizabeth Lightbody, Mairead Reidy, Junko Tsuji, Jean-Baptiste Alberge, Michelle Aranha, Matthew Davids, Maria Papaioannou, Gad Getz, Irene Ghobrial, Salomon Manier et al.

Romanos Sklavenitis-Pistofidis: Establishing targeted therapy for Multiple Myeloma with 1q+

More posts featuring Romanos Sklavenitis-Pistofidis.

Blood Journal cancer Elizabeth Lightbody Gad Getz Irene Ghobrial Jean-Baptiste Alberge Junko Tsuji Mairead Reidy Maria Papaioannou Matthew Davids Michelle Aranha MM multiple myeloma OncoDaily Oncology Romanos Sklavenitis-Pistofidis Salomon Manier
Special Coverage
Science
Mar 15, 2025, 17:51
Romanos Sklavenitis-Pistofidis: Establishing targeted therapy for Multiple Myeloma with 1q+
Positive
Mar 15, 2025, 17:41
Michael Serzan: Medical research saves lives and inspires hope
Blog
Mar 15, 2025, 17:34
Luca De Fiore: Scientists speak out against the EU rearmament proposal
Blog
Mar 15, 2025, 17:16
Catherine Alix-Panabières: Join us at ISMRC 2025 in Nice for AI and Liquid Biopsy breakthroughs
Blog
Mar 15, 2025, 17:09
Loay Kassem: The tumor markers are normal - how could I have cancer?
Blog
Mar 15, 2025, 17:02
Norman Ng: Advocating for affordable cancer treatment for middle-class cancer patients
Science
Mar 15, 2025, 16:53
Tanja Obradovic: Advancing repurposing of approved drugs with Avapritinib for high-grade glioma
Blog
Mar 15, 2025, 16:34
Estela Rodriguez: Why are we still not screening people for lung cancer?
Blog
Mar 15, 2025, 16:29
Misty Dawn Shields: Highlighting lung cancer awareness and screening at the Fight for Air Climb
Positive
Mar 15, 2025, 16:20
Excited to have Citrus Oncology in the CancerX 2025 Accelerator - CancerX
Science
Mar 15, 2025, 16:15
Ramy Sedhom: Real-world challenges in CapeOX tolerability for localized colorectal cancer
Positive
Mar 15, 2025, 15:59
Uniting to end cancer: cross-sector collaboration for health equity - ACS CAN